At a Glance
- Tasks: Lead health economics and outcomes research for innovative medicines and vaccines.
- Company: Join a leading global healthcare company making a real difference in patients' lives.
- Benefits: Enjoy a competitive salary, hybrid working, and opportunities for professional growth.
- Other info: Be part of a dynamic team with excellent career development opportunities.
- Why this job: Make an impact by optimising access to life-changing treatments through strategic health economics.
- Qualifications: Experience in health economics and strong collaboration skills are essential.
The predicted salary is between 80000 - 100000 £ per year.
We have a 12 months fixed-term contract for a Senior Health Economics and Outcomes Research Manager based in Moorgate, London. Our HTA & OR team is one of the largest and busiest teams in the UK. This provides substantial learning and development opportunities as well as making a meaningful difference to people’s lives by enabling national access to the company’s novel medicines and vaccines.
Our company’s HTA team is responsible for submissions to NICE, SMC, AWMSG and the JCVI, as well as supporting the Irish affiliate with NCPE submissions. We support regional and local access through the development of tools and resources. We also lead and support appropriate evidence generation activities. The team is made up of health economists, evidence-based medicine managers and real-world evidence generation experts.
A Senior Health Economics Manager in this team works within a global organisation, collaborating with colleagues around the world, to build and communicate the clinical and economic value of our company’s life-changing medicines. As a member of the HTA & OR team, you will have the opportunity to work with other members of the team, UK cross-functional colleagues, global expert functions, as well as external stakeholders. Cross-functional teamwork - always with patients in mind - is core to the success of the UK team, underpinning every project we do. The company operates on a hybrid working model to support cross-functional collaboration and development. Short notice period will be preferred for this role.
What you will do:
- Lead the HTA process for a single technology or indication for both the health economic and clinical components, with particular focus on the suitability of the economic argument to support the HTA strategy.
- Develop and adapt materials and evidence generation activities to demonstrate the value of company assets under the JCVI’s remit (vaccines and other).
- Optimise the submission strategy, ensuring the economic arguments are appropriate, robust and consistent with the clinical data.
- Lead post submission activities.
- Devise the strategy necessary to optimise success in national value assessment, and ensure the economic model supports this strategy.
- Lead the development of high-quality and robust HTA dossier development and the entirety of the value assessment process (clarification questions, ACD responses etc).
- Manage vendors, ensuring documents meet necessary strategic and technical standards and timelines.
- Support the global organisation’s early health economic model build to ensure an optimal model structure that accommodates UK & Ireland requirements.
- Guide the development and design of UK cost-effectiveness and budget impact models for HTA submissions.
- Represent the company in various settings including NICE Technology Appraisal Committee meetings, scoping meetings, advisory boards.
- Use of real-world data to address data gaps to support national access decisions and uptake.
- Engage with customers and external stakeholders to better understand the real world environment for any technology.
- Communicate regularly with cross-functional teams on appraisal risks and opportunities.
Evidence generation:
- Lead evidence generation activities that address gaps particularly of relevance to HTA/JCVI dossiers.
- Support generation of economic evidence to support lifecycle management, uptake and implementation of novel treatments.
- Contribute to and/or lead health economic methodological research initiatives.
Lifecycle management:
- Conduct landscape assessments for products in the pipeline, focusing on HTA and health economic risks and mitigations.
- Support New Product Planning colleagues to ensure that HTA requirements are anticipated in the development of UK launch plans.
- Contribute to cross-functional strategy sessions with medical, marketing, market access, and external affairs colleagues.
Development, capability building, compliance, routine business activities:
- Contributing to the development of technical expertise both within the HTA & OR team and the broader company.
- Keep up to date on best practice statistical and health economic methods, clinical trial design and reporting.
- Coach and mentor health economics managers in the team on technical methods.
Required Skills: Cross-Functional Collaboration, Health Economics, Health Outcomes Research, Stakeholder Relationship Management, Strategic Planning, Vendor Management.
Preferred Skills: Employee Status: Temporary (Fixed Term).
Senior Health Economics and Outcomes Research Manager (Associate Director level)- 12 months Fix[...] employer: EyeBio
EyeBio is an exceptional employer that fosters a dynamic and collaborative work culture, where innovation and strategic thinking are highly valued. With a focus on employee growth, the company offers ample opportunities for professional development and career advancement, all while enjoying the vibrant atmosphere of London. The hybrid working model ensures a healthy work-life balance, making EyeBio an attractive choice for those seeking meaningful and rewarding employment in the pharmaceutical sector.